Zentalis Pharmaceuticals, LLC (ZNTL)
Zentalis Pharmaceuticals (ZNTL) sees social dominance surge 150.77% as positive Phase [--] data for ZN-c3 fuels investor optimism. However, concerns linger regarding regulatory approval and manufacturing scale-up.
About Zentalis Pharmaceuticals, LLC
Zentalis Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on developing novel cancer therapies.
Zentalis Pharmaceuticals, LLC uses the ticker $ZNTL for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Zentalis Pharmaceuticals, LLC (ZNTL) social dominance is up 150.77% from the previous week.
Price: $2.40
Price 24-Hour Time-Series Raw Data
The stock price has seen a recent upward trend, likely driven by positive Phase [--] data for ZN-c3, indicating investor optimism. However, concerns about regulatory approval timelines and manufacturing scale-up may be limiting more substantial gains.
24-Hour: 2.14% 7-Day: 0.26% 30-Day: -19.26%
1-Year High: $3.70 on 2026-01-09
1-Year Low: $1.20 on 2025-06-30
AltRank: [-----]
AltRank 24-Hour Time-Series Raw Data
Zentalis Pharmaceuticals, LLC (ZNTL) is currently AltRank #1,952 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] [---]
1-Year High: [-----] on 2026-01-28
1-Year Low: [---] on 2026-01-25
Galaxy Score: [-----]
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
1-Year High: [--] on 2026-02-03
1-Year Low: [--] on 2026-02-05
Engagements: [---] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -12%
[--] Month: [------] -79%
[--] Months: [-------] +47%
[--] Year: [-------] -61%
1-Year High: [------] on 2026-01-12
1-Year Low: [--] on 2025-09-07
Engagements by network (24h): X: [---] YouTube: [--] TikTok: [--] Reddit: [--]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [---] -44%
1-Year High: [---] on 2026-01-11
1-Year Low: [--] on 2025-12-07
Mentions by network (24h): X: [--] YouTube: [--] TikTok: [--] Reddit: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Zentalis Pharmaceuticals, LLC (ZNTL) in the last [--] hours which is down 65% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] -37%
1-Year High: [---] on 2026-01-10
1-Year Low: [--] on 2025-12-07
Sentiment: 100%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 89%
[--] Week: 100% no change
[--] Month: 100% +16%
[--] Months: 100% no change
[--] Year: 100% no change
1-Year High: 100% on 2025-02-17
1-Year Low: 33% on 2025-05-29
Most Supportive Themes:
- Zentalis Pharmaceuticals Announces Positive Phase [--] Data for ZN-c3: (70%) Zentalis Pharmaceuticals LLC presented encouraging Phase [--] clinical trial results for their drug candidate ZN-c3, showing significant efficacy in treating certain types of cancer. The data has been met with enthusiasm from the oncology community and investors.
- Zentalis Expands Clinical Trial Pipeline with New Cancer Targets: (30%) The company is broadening its research and development efforts, initiating new clinical trials for ZN-c3 and other promising compounds targeting various advanced cancers. This expansion signals a commitment to addressing unmet medical needs.
Most Critical Themes:
- Regulatory Hurdles and Competition in Oncology Drug Development: (60%) Zentalis Pharmaceuticals faces a competitive landscape and stringent regulatory pathways for new cancer therapies. The success of ZN-c3 will depend on navigating these challenges effectively and demonstrating a clear advantage over existing treatments.
- Manufacturing Scale-Up and Supply Chain Considerations for ZN-c3: (40%) Ensuring a robust and scalable manufacturing process for ZN-c3 is crucial for its eventual market availability. Potential supply chain disruptions or manufacturing complexities could impact the drug's timely delivery to patients.
Social Dominance: 0.00162%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00162%
Daily Average: 0.00466%
[--] Week: 0.00326% +0.00196%
[--] Month: 0.0026% -0.013%
[--] Months: 0.0026% +0.0011%
[--] Year: 0.0026% -0.0051%
1-Year High: 0.061% on 2026-01-11
1-Year Low: 0.0002% on 2025-10-04
Market Dominance: 0.00017530143017276887%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00017530143017276887%
Daily Average: 0%
1-Year High: 0.00726% on 2026-01-13
1-Year Low: 0.00018% on 2026-02-16
Market Cap: $154,754,362
Market Cap 24-Hour Time-Series Raw Data
Current Value: $154,754,362
Daily Average: $174,568,100
[--] Week: $153,679,499 -0.69%
[--] Month: $154,754,362 -19%
1-Year High: $227,275,234 on 2026-01-14
1-Year Low: $143,099,222 on 2026-02-05
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing